Innovation1 Biotech (Innovation1 Biotech) Operating Cash Flow per Share : $-0.03 (TTM As of Aug. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech Operating Cash Flow per Share?

Innovation1 Biotech's operating cash flow per share for the three months ended in Aug. 2023 was $-0.00. Innovation1 Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Aug. 2023 was $-0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 71.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 53.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Innovation1 Biotech's Operating Cash Flow per Share or its related term are showing as below:

IVBT' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -502 Med: -6.65 Max: 71.7
Current: 71.7

During the past 9 years, Innovation1 Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 71.70% per year. The lowest was -502.00% per year. And the median was -6.65% per year.

IVBT's 3-Year OCF Growth Rate is ranked better than
93.04% of 115 companies
in the Diversified Financial Services industry
Industry Median: 10.6 vs IVBT: 71.70

Innovation1 Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Innovation1 Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech Operating Cash Flow per Share Chart

Innovation1 Biotech Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.78

-1.37

-0.16

-0.21

-0.03

Innovation1 Biotech Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.02	-0.01	-0.01	-0.01	-

Competitive Comparison of Innovation1 Biotech's Operating Cash Flow per Share

For the Shell Companies subindustry, Innovation1 Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation1 Biotech's Price-to-Operating-Cash-Flow Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's Price-to-Operating-Cash-Flow falls into.

Innovation1 Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Innovation1 Biotech's Operating Cash Flow per Share for the fiscal year that ended in Aug. 2023 is calculated as

Operating Cash Flow per Share (A: Aug. 2023 )	=	Cash Flow from Operations (A: Aug. 2023 )	/	Shares Outstanding (Diluted Average) (A: Aug. 2023 )
	=	-0.62	/	20.184
	=	-0.03

Innovation1 Biotech's Operating Cash Flow per Share for the quarter that ended in Aug. 2023 is calculated as

Operating Cash Flow per Share (Q: Aug. 2023 )	=	Cash Flow from Operations (Q: Aug. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Aug. 2023 )
	=	-0.027	/	20.473
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

Innovation1 Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovation1 Biotech (Innovation1 Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Wall Street, Suite 2701, New York, NY, USA, 10005

Website

https://www.innovation1bio.com

Innovation1 Biotech Inc is a shell company.

Executives

Grays Peak Llc	10 percent owner	8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr	director, 10 percent owner, officer: President	4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long	director, 10 percent owner, officer: CEO & Secretary	4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho	director, 10 percent owner, officer: Treasurer	4010 EAST TANAGER LANE, MEAD WA 99021